Synopsis of recent research by authors named "Shiguai Qi"
- Shiguai Qi's recent research primarily focuses on hepatocellular carcinoma (HCC), investigating various treatment modalities and prognostic factors to improve patient outcomes, particularly in surgical contexts and adjuvant therapies.
- A significant study compares neoadjuvant therapies (HAIC combined with Lenvatinib) against direct liver resection, aiming to establish more effective pre-surgical treatments for resectable HCC cases, alongside a meta-analysis on hypothermic oxygenated perfusion versus static cold storage in liver transplantation.
- Other studies emphasize biomarkers in drug sensitivity screening, portal vein thrombosis post-hepatectomy, and develop predictive algorithms for evaluating adjuvant therapies, thereby contributing to enhanced personalized treatment approaches and better understanding of recurrence in liver cancer patients.